(TBPH) Theravance Biopharma complete technical analysis [charts+indicators] | Buy/Sell Theravance Biopharma | (TBPH) share price targets
Complete technical analysis of Theravance Biopharma (TBPH) by charts plus indicators, forecast predictions and share price targets for Theravance Biopharma (TBPH)
Theravance Biopharma trades in USA in Health Care sector.
Showing technical analysis as on 2025-03-19 View latest technical analysis
10 day averaged volume of Theravance Biopharma is 217727
| Date | Daily Closing Price | Open | High | Low | Volume |
| 19 Wed Mar 2025 | 9.47 | 9.22 | 9.50 | 9.19 | 0.461 times |
| 18 Tue Mar 2025 | 9.21 | 9.32 | 9.50 | 9.21 | 0.825 times |
| 17 Mon Mar 2025 | 9.35 | 9.24 | 9.44 | 9.24 | 0.768 times |
| 14 Fri Mar 2025 | 9.23 | 9.31 | 9.40 | 9.23 | 1.55 times |
| 13 Thu Mar 2025 | 9.28 | 9.39 | 9.39 | 9.06 | 0.847 times |
| 12 Wed Mar 2025 | 9.44 | 9.34 | 9.52 | 9.16 | 0.786 times |
| 11 Tue Mar 2025 | 9.29 | 9.41 | 9.47 | 9.12 | 1.076 times |
| 10 Mon Mar 2025 | 9.46 | 9.47 | 9.70 | 9.37 | 0.683 times |
| 07 Fri Mar 2025 | 9.53 | 9.64 | 9.91 | 9.53 | 0.625 times |
| 06 Thu Mar 2025 | 9.71 | 9.66 | 9.89 | 9.60 | 1.255 times |
My analysis of stock is bullish for shortterm, but stock is in semi over bought zones and there are some chances of seeing a fall tomorrow. Use 9.5 as stoploss in an intra day sell trade for a target of 9.32. However, stock will show a bullish move above 9.5.
Share price targets for Theravance Biopharma (TBPH)
| Target Type | Value |
| Downside Target | 8.14 |
| Downside Target | 8.35 |
| Downside Target | 8.78 |
| Downside Target | 9.01 |
| Upside Target | 9.70 |
| Upside Target | 9.91 |
| Upside Target | 10.05 |
| Upside Target | 10.19 |
| Upside Target | 10.25 |
| Upside Target | 10.26 |
| Upside Target | 10.90 |
Intraday share price targets for Theravance Biopharma (TBPH)
| Target Type | Value |
| Downside Intraday Target | 9.27 |
| Downside Intraday Target | 9.08 |
| Upside Intraday Target | 9.58 |
| Upside Intraday Target | 9.7 |
| Downside Intraday Target | 9.39 |
Weekly technical analysis of Theravance Biopharma (TBPH)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 19 Wed Mar 2025 | 9.47 | 9.24 | 9.50 | 9.19 | 0.416 times |
| 14 Fri Mar 2025 | 9.23 | 9.47 | 9.70 | 9.06 | 0.781 times |
| 07 Fri Mar 2025 | 9.53 | 9.31 | 9.91 | 9.01 | 0.498 times |
| 28 Fri Feb 2025 | 9.35 | 9.30 | 10.19 | 8.78 | 3.187 times |
| 21 Fri Feb 2025 | 9.32 | 9.70 | 10.05 | 9.27 | 1.129 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Theravance Biopharma (TBPH)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 19 Wed Mar 2025 | 9.47 | 9.31 | 9.91 | 9.01 | 0.551 times |
| 28 Fri Feb 2025 | 9.35 | 9.25 | 10.19 | 8.78 | 1.193 times |
| 31 Fri Jan 2025 | 9.38 | 9.46 | 10.90 | 8.35 | 1.632 times |
| 31 Tue Dec 2024 | 9.41 | 9.89 | 10.25 | 9.34 | 0.621 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Theravance Biopharma (TBPH)
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Theravance Biopharma stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Theravance Biopharma in short term but the sell signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Theravance Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Theravance Biopharma in short term but BUY signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Theravance Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 9.39 and Theravance Biopharma (TBPH) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Theravance Biopharma (TBPH) stock. Volume based technical analysis of Theravance Biopharma (TBPH) stock is negative.
Theravance Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Theravance Biopharma stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Theravance Biopharma in short term but the sell signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Theravance Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Theravance Biopharma in short term but BUY signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Theravance Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 9.39 and Theravance Biopharma (TBPH) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Theravance Biopharma (TBPH) stock. Volume based technical analysis of Theravance Biopharma (TBPH) stock is negative.
Theravance Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.